Iterum Therapeutics plc (ITRMF) Debt Ratio (2018 - 2024)

Iterum Therapeutics has reported Debt Ratio for 7 years, with the latest figure at 0.32 in Q4 2024.

• On a quarterly basis, Debt Ratio fell 25.64% year-over-year to 0.32 in Q4 2024; TTM through Dec 2024 was 0.32, a 25.64% decrease from a year earlier, with the FY2024 full-year figure at 0.32, down 25.64% from the prior year.
• Debt Ratio was 0.32 for Q4 2024 at Iterum Therapeutics, down from 0.86 in the prior quarter.
• The five-year high for Debt Ratio was 2.05 in Q3 2020, with the low at 0.13 in Q2 2022.
• Average Debt Ratio over 5 years is 0.61, with a median of 0.32 recorded in 2023.
• The sharpest annual moves came in 2020 and 2021: Debt Ratio surged 723.7% in 2020, then slumped 90.92% in 2021.
• Over 5 years, Debt Ratio stood at 1.76 in 2020, then plunged by 90.92% to 0.16 in 2021, then retreated by 3.6% to 0.15 in 2022, then soared by 183.28% to 0.44 in 2023, then dropped by 25.64% to 0.32 in 2024.
• The last three Debt Ratio figures came in at 0.32 (Q4 2024), 0.86 (Q3 2024), and 0.91 (Q2 2024), per Business Quant data.